4.7 Article

Design, construction and in vitro testing of zinc finger nucleases

Journal

NATURE PROTOCOLS
Volume 1, Issue 3, Pages 1329-1341

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2006.231

Keywords

-

Funding

  1. NATIONAL CANCER INSTITUTE [R21CA103651] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065173, R01GM058504] Funding Source: NIH RePORTER
  3. NCI NIH HHS [R21 CA103651, CA103651, R21 CA103651-02] Funding Source: Medline
  4. NIGMS NIH HHS [GM65173, GM58504] Funding Source: Medline

Ask authors/readers for more resources

Zinc finger nucleases (ZFNs) are hybrid proteins that have been developed as targetable cleavage reagents for double-stranded DNA, both in vitro and in vivo. This protocol describes the design and construction of new DNA-binding domains comprised of zinc fingers (ZFs) directed at selected DNA sequences. Because the ZFNs must dimerize to cut DNA, they are designed in pairs for any new site. The first step is choosing a DNA segment of interest and searching it for sequences that can be recognized by combinations of existing ZFs. The second step is the construction of coding sequences for the selected ZF sets. Third, these coding sequences are linked to that of the nonspecific cleavage domain from the FokI restriction endonuclease in a cloning vector of choice. Finally, the ZFNs are expressed in Escherichia coli, partially purified, and tested in vitro for cleavage of the target sequences to which they were designed. If all goes smoothly, design, construction and cloning can be completed in about two weeks, with expression and testing completed in one additional week.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available